COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection

William M Stauffer^{1

2}, Jonathan D Alpern^{3

4}, Patricia F Walker^{2

3}

Affiliations

¹ Center for Global Health and Social Responsibility, University of Minnesota, Minneapolis.
² Department of Medicine, Global Medicine, University of Minnesota, Minneapolis.
³ HealthPartners Institute, Bloomington, Minnesota.
⁴ HealthPartners Travel and Tropical Medicine Center, St Paul, Minnesota.

William M Stauffer et al. JAMA. 2020.

. 2020 Aug 18;324(7):623-624.

doi: 10.1001/jama.2020.13170.

William M Stauffer^{1

2}, Jonathan D Alpern^{3

4}, Patricia F Walker^{2

3}

¹ Center for Global Health and Social Responsibility, University of Minnesota, Minneapolis.
² Department of Medicine, Global Medicine, University of Minnesota, Minneapolis.
³ HealthPartners Institute, Bloomington, Minnesota.
⁴ HealthPartners Travel and Tropical Medicine Center, St Paul, Minnesota.

No abstract available

Comment in

Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19.
De Wilton A, Nabarro LE, Godbole GS, Chiodini PL, Boyd A, Woods K. De Wilton A, et al. Travel Med Infect Dis. 2021 Mar-Apr;40:101981. doi: 10.1016/j.tmaid.2021.101981. Epub 2021 Jan 31. Travel Med Infect Dis. 2021. PMID: 33535106 Free PMC article. No abstract available.